The healthcare community is buzzing by retatrutide, a novel dual GIP and GLP-1 agonist that’s showing impressive results in clinical research. This treatment works by replicating natural hormones to affect appetite and promote feelings of satisfaction , ultimately resulting in noticeable weight r